Guide · Updated 2026
GLP-1 Shortage Update 2026
After two years of chaos, the US GLP-1 supply is mostly stable — but the compounding rules and pharmacy dynamics have changed permanently.
Current supply status
| Drug | Status | Notes |
|---|---|---|
| Ozempic | Available | All doses generally stocked. Sporadic local outages. |
| Wegovy | Available | 0.25 mg and 2.4 mg occasionally short. NovoCare Pharmacy direct fulfillment. |
| Mounjaro | Available | All doses stocked. LillyDirect available. |
| Zepbound | Available (pens + vials) | LillyDirect single-dose vials ($349–$499/mo cash) most reliable path. |
| Saxenda | Available | Stable supply throughout. |
| Rybelsus | Available | All strengths stocked. |
What changed with compounding
During the FDA-declared shortage, 503A and 503B compounding pharmacies were permitted to produce copies of semaglutide and tirzepatide. When each shortage was resolved (semaglutide in early 2025, tirzepatide in late 2024), that exemption ended.
Compounding is now legal only when a specific patient needs a formulation the commercial drug can't provide — for example, a documented allergy to a pen excipient or a dose that isn't manufactured. Mass compounded semaglutide sold as a cheaper alternative to Wegovy is no longer legal.
Legitimate cash-pay alternatives
- LillyDirect (Zepbound vials): $349 for 2.5/5 mg, $499 for 7.5/10 mg, monthly. Shipped from a Lilly-partnered pharmacy.
- NovoCare Pharmacy (Wegovy): $499/mo cash regardless of dose. Direct from Novo Nordisk.
- Manufacturer savings cards: Commercial insurance holders can drop copays to $25–$100 for eligible drugs.
- Legitimate compounders: Only with documented clinical need. Verify pharmacy license and 503A/B status.
What to do if your pharmacy is out
- Call 2–3 other pharmacies in your area before switching drugs.
- Try mail-order via LillyDirect, NovoCare, or your PBM's specialty pharmacy.
- If a specific dose is out, ask your prescriber for a different dose that's in stock — an interim step-down or step-up may be safe.
- Do not extend the dosing interval (skipping weeks) without prescriber approval.
Red flags for illegal semaglutide
- Marketed as "research-only" or "not for human use"
- Prices dramatically below LillyDirect and NovoCare
- Sold as powder for reconstitution without a licensed pharmacist involved
- No prescription required
- Ships from overseas
FAQ
Is there still a GLP-1 shortage?
The FDA declared the tirzepatide and semaglutide shortages resolved. Most doses are consistently in stock, though occasional local pharmacy stockouts still happen.
Can pharmacies still compound semaglutide or tirzepatide?
Only in limited circumstances — for individual patients with clinical need documented by a prescriber. Mass compounding under the shortage exemption is no longer permitted.
Which dose is hardest to find?
Historically the starter doses (Wegovy 0.25 mg, Zepbound 2.5 mg). By late 2026 most are consistently stocked.
Should I stockpile?
No. Pens have expiration dates and refrigeration requirements. A 30–60 day buffer is reasonable; hoarding contributes to shortages.
What if my pharmacy is out?
Try another local pharmacy, mail-order specialty pharmacies (Lilly Direct, NovoCare), or ask your prescriber for a different dose that's in stock.
See which providers match your situation
Take a 90-second questionnaire and we'll rank your top 3 telehealth providers by medication, budget, and state availability.
Find My Top 3 MatchesEducational content, not medical advice. Talk to a licensed clinician before starting or changing any medication.